rs181285048

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_022725.4(FANCF):​c.*1484G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00832 in 213,688 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0081 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0090 ( 3 hom. )

Consequence

FANCF
NM_022725.4 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.109

Publications

2 publications found
Variant links:
Genes affected
FANCF (HGNC:3587): (FA complementation group F) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group F. [provided by RefSeq, Jul 2008]
FANCF Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group F
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 11-22623202-C-T is Benign according to our data. Variant chr11-22623202-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 877849.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00806 (1227/152276) while in subpopulation NFE AF = 0.013 (887/68014). AF 95% confidence interval is 0.0123. There are 5 homozygotes in GnomAd4. There are 566 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCFNM_022725.4 linkc.*1484G>A 3_prime_UTR_variant Exon 1 of 1 ENST00000327470.6 NP_073562.1 Q9NPI8A3KME0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCFENST00000327470.6 linkc.*1484G>A 3_prime_UTR_variant Exon 1 of 1 6 NM_022725.4 ENSP00000330875.3 Q9NPI8

Frequencies

GnomAD3 genomes
AF:
0.00806
AC:
1227
AN:
152158
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0137
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0130
Gnomad OTH
AF:
0.00478
GnomAD4 exome
AF:
0.00897
AC:
551
AN:
61412
Hom.:
3
Cov.:
0
AF XY:
0.00907
AC XY:
258
AN XY:
28446
show subpopulations
African (AFR)
AF:
0.00105
AC:
3
AN:
2848
American (AMR)
AF:
0.00385
AC:
7
AN:
1816
Ashkenazi Jewish (ASJ)
AF:
0.00608
AC:
24
AN:
3948
East Asian (EAS)
AF:
0.00
AC:
0
AN:
9054
South Asian (SAS)
AF:
0.00
AC:
0
AN:
518
European-Finnish (FIN)
AF:
0.0238
AC:
1
AN:
42
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
382
European-Non Finnish (NFE)
AF:
0.0125
AC:
471
AN:
37668
Other (OTH)
AF:
0.00876
AC:
45
AN:
5136
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
28
56
84
112
140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00806
AC:
1227
AN:
152276
Hom.:
5
Cov.:
33
AF XY:
0.00760
AC XY:
566
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00265
AC:
110
AN:
41562
American (AMR)
AF:
0.00372
AC:
57
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.0137
AC:
145
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0130
AC:
887
AN:
68014
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
60
120
180
240
300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0110
Hom.:
1
Bravo
AF:
0.00750
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Fanconi anemia complementation group F Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.93
DANN
Benign
0.23
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181285048; hg19: chr11-22644748; API